Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 17
Trial IDs: AECM-CCI-2005-536, NCI-2010-00890, AECM-CCI-05-428, AECM-MMC-05-10-265C, NCT00450944
Immunotoxin Therapy and Cytarabine in Treating Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 65
Trial IDs: 11-04-146, NCI-2013-01206, 11-027, NCT01408160
Start Over